Literature DB >> 8395681

Biological and biochemical activity of E7 genes of the cutaneous human papillomavirus type 5 and 8.

T Yamashita1, K Segawa, Y Fujinaga, T Nishikawa, K Fujinaga.   

Abstract

In contrast to the observed activity of the E7 genes of the genital high-risk human papillomavirus (HPV)16 and HPV18, E7s of the cutaneous high-risk HPV5 and HPV8 show no in vitro transforming activity in established rodent cells. We recently reported that the HPV8 E7 driven by the SV40 enhancer/promoter oncogenically transforms primary rat embryo fibroblast (REF) cells collaboratively with the EJras oncogene (Jpn. J. Cancer Res., 82, 1340-1343, 1991). To study the functional differences between cutaneous HPV5 and HPV8 E7s and genital HPV16 E7, we cloned each of the E7 open reading frames and tested their immortalizing and transforming activities, the binding ability of their products with retinoblastoma protein (RB) and their complementation activity of a RB-nonbinding adenovirus E1A mutant. In contrast to results with HPV16 E7, transfection of HPV5 and HPV8 E7s did not produce any G418-resistant colonies in primary baby rat kidney (BRK) cells. However, they induced morphological transformation of primary BRK cells as well as of primary REF cells when cotransfected with the EJras oncogene. The ras-cooperating activity of HPV8 E7 appears to be extremely low, since, unlike the case of HPV5 and HPV16 E7s, transformed BRK colonies induced by HPV8 E7 plus ras have had a very low survival rate. The in vitro RB binding experiment showed that HPV5 and 8 E7s are able to form complexes with RB protein with reduced affinities of about one fourth and one nineteenth that of HPV16 E7, respectively. Moreover, not only HPV16 E7 but also HPV5 and 8 E7s complemented a nontransforming adenovirus 5 E1A mutant (dl922/947) incapable of binding to RB in inducing E1A-specific transformed foci on primary BRK cells. Since both the activities, the ras-collaborative transformation and complementation of the inert E1A mutant by E7s, all correlate with in vitro RB binding affinity (HPV16 E7 > HPV5 E7 > HPV8 E7), it is likely that RB binding of HPV5 and HPV8 E7s is an integral part of the biological activities of these proteins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8395681

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

Review 1.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

2.  Nuclear import of cutaneous beta genus HPV8 E7 oncoprotein is mediated by hydrophobic interactions between its zinc-binding domain and FG nucleoporins.

Authors:  Zeynep Onder; Junona Moroianu
Journal:  Virology       Date:  2013-12-05       Impact factor: 3.616

3.  E7 proteins of four groups of human papillomaviruses, irrespective of their tissue tropism or cancer association, possess the ability to transactivate transcriptional promoters E2F site dependently.

Authors:  A Hiraiwa; T Kiyono; S Suzuki; M Ohashi; M Ishibashi
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

4.  Identification of six putative novel human papillomaviruses (HPV) and characterization of candidate HPV type 87.

Authors:  S Menzo; A Monachetti; C Trozzi; A Ciavattini; G Carloni; P E Varaldo; M Clementi
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Skin hyperproliferation and susceptibility to chemical carcinogenesis in transgenic mice expressing E6 and E7 of human papillomavirus type 38.

Authors:  Wen Dong; Ulrich Kloz; Rosita Accardi; Sandra Caldeira; Wei-Min Tong; Zhao-Qi Wang; Lars Jansen; Matthias Dürst; Bakary S Sylla; Lutz Gissmann; Massimo Tommasino
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

6.  Induction of transformation and p53-dependent apoptosis by adenovirus type 5 E4orf6/7 cDNA.

Authors:  S Yamano; T Tokino; M Yasuda; M Kaneuchi; M Takahashi; Y Niitsu; K Fujinaga; T Yamashita
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  Nuclear export of cutaneous HPV8 E7 oncoprotein is mediated by a leucine-rich nuclear export signal via a CRM1 pathway.

Authors:  Zeynep Onder; Vivian Chang; Junona Moroianu
Journal:  Virology       Date:  2014-11-09       Impact factor: 3.616

Review 8.  The papillomavirus E7 proteins.

Authors:  Ann Roman; Karl Munger
Journal:  Virology       Date:  2013-05-31       Impact factor: 3.616

9.  The E6 oncoproteins from human betapapillomaviruses differentially activate telomerase through an E6AP-dependent mechanism and prolong the lifespan of primary keratinocytes.

Authors:  Kristin M Bedard; Michael P Underbrink; Heather L Howie; Denise A Galloway
Journal:  J Virol       Date:  2008-02-06       Impact factor: 5.103

10.  A humanized mouse model of HPV-associated pathology driven by E7 expression.

Authors:  Águeda Buitrago-Pérez; Mariam Hachimi; Marta Dueñas; Belén Lloveras; Almudena Santos; Almudena Holguín; Blanca Duarte; Juan Luis Santiago; Baki Akgül; José L Rodríguez-Peralto; Alan Storey; Catalina Ribas; Fernando Larcher; Marcela del Rio; Jesús M Paramio; Ramón García-Escudero
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.